• Biosimilars
  • Drug Development/R&D
  • All Topics
OHE OHE
Newsletter SignupSubscribe

News & Insights
  • News
  • Events
  • Insights
  • Bulletin
  • News
  • Events
  • Insights
  • Bulletin

News & Insights

  • News
  • Events
  • Insights
  • Bulletin
Newsletter SignupSubscribe
  • News
  • Events
  • Insights
  • Bulletin

Close
OHE OHE
  • Research & Publications
  • News & Insights
  • Education
  • Innovation Policy Prize
  • Events
  • About Us
  • OHE Experts
  • Contact Us
Newsletter SignupSubscribe

Research & Publications

All Publications

Filter by:
  • Antimicrobial Resistance (AMR)
  • Biosimilars
  • Cell and Gene Therapies
  • Chronic Diseases
  • Combination Therapies
  • COVID-19 Research
  • Digital Health
  • Drug Development/R&D
  • Emerging Markets
  • EQ-5D and PROMs
  • Health Care Systems
  • Health Data and Statistics
  • Health Technology Assessment
  • Precision Medicine
  • Real World Evidence
  • Use of Medicines
  • Value-Based Pricing
  • Vaccine Research
  • Economics of Innovation
  • Measuring and Valuing Outcomes
  • Policy, Organisation and Incentives in Health Systems
  • Value, Affordability and Decision Making

News & Insights

  • News
  • Events
  • Insights
  • Bulletin

Education

  • Education Hub
  • OHE Graduate School
  • EVIA Programme

Innovation Policy Prize

  • The Prize Fund
  • 2022 Prize Fund

Latest Research & Publications

Proposal for a General Outcome-based Value Attribution Framework for Combination Therapies

CombTher_Adobe_photoguns_portrait
Read more
© photoguns
  • Digital Health

Navigating the Landscape of Digital Health – United Kingdom

Healthcare_Adobe_elenabsl
Read more

2021 OHE Annual Report to the Charity Commission

charityreport_lina-trochez-unsplash_landscape
Read more
© Lina Trochez/Unsplash

Supporting the Era of Green Pharmaceuticals in the UK

Sustainability_AdobeStock_270582392_landscape
Read more

Quality of life and wellbeing in individuals with experience of fertility problems and assisted reproductive techniques

Quality of life assisted reproduction Cover
Read more
  • Cell and Gene Therapies
  • Value, Affordability, and…

Health Technology Assessment of Gene Therapies: Are Our Methods Fit for Purpose?

gene_therapies_national-cancer-institute-unsplash_landscape
Read more
© NCI/Unsplash
  • Drug Development/R&D
  • Economics of Innovation
  • Health Policy and Regulation

Limitations of CBO’s Simulation Model of New Drug Development as a Tool for Policymakers

CBO-US_mayer-tawfik-K4Ckc0AxgDI-unsplash_landscape
Read more
© Mayer Tawfik/Unsplash
  • Measuring and Valuing Outcomes

When Generic Measures Fail to Reflect What Matters to Patients: Three Case Studies

PROMS_unsplash_National Cancer Institute_landscape
Read more
© NCI/Unsplash
Close
OHE
  • All Publications

    Filter by:
    • Antimicrobial Resistance (AMR)
    • Biosimilars
    • Cell and Gene Therapies
    • Chronic Diseases
    • Combination Therapies
    • COVID-19 Research
    • Digital Health
    • Drug Development/R&D
    • Emerging Markets
    • EQ-5D and PROMs
    • Health Care Systems
    • Health Data and Statistics
    • Health Technology Assessment
    • Precision Medicine
    • Real World Evidence
    • Use of Medicines
    • Value-Based Pricing
    • Vaccine Research
    • Economics of Innovation
    • Measuring and Valuing Outcomes
    • Policy, Organisation and Incentives in Health Systems
    • Value, Affordability and Decision Making
    • News
    • Events
    • Insights
    • Bulletin
    • Education Hub
    • OHE Graduate School
    • EVIA Programme
    • The Prize Fund
    • 2022 Prize Fund
  • Events
  • About Us
  • OHE Experts
  • Contact Us
Newsletter SignupSubscribe
Back
  • News
11 min read 1st November 2016

New OHE Research Paper: The Distribution of the EQ-5D-5L Index in Patient Populations

Just published is a new OHE Research paper entitled ‘The Distribution of the EQ-5D-5L Index in Patient Populations’. EQ-5D data are often summarised by an EQ-5D index. The distribution for the original version of the index, the EQ-5D-3L, often shows…

Share:
  •  Twitter
  •  LinkedIn
  •  Facebook
  • has-icon Email

Just published is a new OHE Research paper entitled ‘The Distribution of the EQ-5D-5L Index in Patient Populations’.

EQ-5D data are often summarised by an EQ-5D index. The distribution for the original version of the index, the EQ-5D-3L, often shows two distinct groups in patient populations. This is a result of both the distribution of ill health and how the index is constructed (Parkin et al., 2016). To date, there is little evidence available about the distribution of the EQ-5D-5L index. This project aims to:

  • explore whether or not the EQ-5D-5L index distribution also demonstrates this two-group distribution
  • test the extent to which clustering of EQ-5D-5L profile data drives any observed clustering of the EQ-5D-5L index, and the extent to which clusters result from the characteristics of the value sets used to create the index;
  • discuss the implications of our results for statistical analysis of EQ-5D-5L index data.

Data from Cambridgeshire Community Services NHS’s electronic patient records data warehouse were analysed. EQ-5D-5L profiles before treatment were obtained for 30,284 patients across three patient groups: community rehabilitation services (N=6,919); musculoskeletal therapy services (N=19,999); and nursing services (N=3,366).

The EQ-5D-5L index is calculated using both a ‘mapped’ (crosswalk) value set (MVS) and the English value set (EVS). We examined the distribution of 1,730 of the 3,125 profiles described by the EQ-5D-5L to check for clustering of the EQ-5D-5L index. The k-means cluster method and the Calinski–Harabasz pseudo-F index stopping rule were used to search for the clusters in the index. We examined the impact on the results of using different initial values in the clustering analysis.

Clustering within the EQ-5D-5L index distribution is suggested by both clustering methods, within each of the three patient groups and all patients together. For the all patients’ data, we found two robust clusters for the MVS-based index, compared to three robust clusters for the EVS-based index. The EQ-5D-5L profile data alone do not obviously drive these index clusters.

The results highlight the importance of undertaking careful exploratory data analysis for health related quality of life measures such as the EQ-5D, to ensure that statistical testing takes account of clustering and other features of the data distribution.

The paper was authored by OHE’s Yan Feng, Nancy Devlin, Bernarda Zamora and David Parkin, and Andrew Bateman of the Cambridgeshire Community Services NHS Trust and University of Cambridge.

To access the full paper click here.

This project was funded by a research grant from the EuroQol Research Foundation. The research was also supported by the National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care East of England at Cambridgeshire and Peterborough NHS Foundation Trust.

For more information about OHE’s programme of EuroQol-related research, please contact Nancy Devlin.

  • EQ-5D and PROMs
  • Measuring and Valuing Outcomes
  • Research Papers

Related News

  • News
  • December 2020

Should We ‘Drop Dead’ from Health State Valuation?

Read more
  • News
  • September 2020

Cornerstones of ‘Fair’ Drug Coverage

Read more
  • News
  • January 2020

Anchoring Latent Scale Values for the EQ-5D-Y at 0 = Dead

Read more
  • News
  • September 2019

HTA and Payment Mechanisms for New Drugs to Tackle AMR

Read more
footer_ohe_logo

Leading intellectual authority on global health economics

Sign Up for the OHE News Bulletin

Newsletter SignupStart Sign Up

Research & Publications

News & Insights

Innovation Policy Prize

Education

Events

About Us

OHE Experts

Contact Us

Sign Up for the OHE News Bulletin

Newsletter SignupStart Sign Up

The Office of Health Economics (OHE) is a company limited by guarantee registered in England and Wales (registered number 09848965) and its registered office is at 2nd Floor Goldings House, Hay’s Galleria, 2 Hay’s Lane, London, SE1 2HB.

Terms & Conditions

Privacy Policy

Cookies Policy

© 2023 Website Design

An error has occurred, please try again later.An error has occurred, please try again later.

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in settings.

 Twitter
 Facebook
 LinkedIn
 Copy
 Email
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

3rd Party Cookies

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.

Please enable Strictly Necessary Cookies first so that we can save your preferences!